- OncoGenex Pharmaceuticals (OGXI +2.3%) Q1 results: Revenues: $1.4M (-88.0%); R&D Expense: $3.7M (-78.1%); SG&A: $2.7M (-3.6%); Operating Loss: ($5M) (+36.7%); Net Loss: ($4.5M) (+47.7%); Loss Per Share: ($0.20) (+66.1%); Quick Assets: $40.6M (-14.2%).
- No guidance given.
OncoGenex Pharma reports Q1 results
Recommended For You
More Trending News
About ACHV Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ACHV | - | - |
Achieve Life Sciences, Inc. |